02/15/2012 - 10:57am

Drug maker Biogen Idec plans to spend up to more than $560 million to buy a company developing treatments for organ failure.

02/14/2012 - 12:10pm

The Food and Drug Administration is giving priority review to a drug made by Gilead Sciences that the company is investigating for the prevention of HIV.

02/14/2012 - 10:51am

Bristol-Myers Squibb has completed its acquisition of a developer of hepatitis C treatments.

02/13/2012 - 10:23am

Valeant Pharmaceuticals is set to acquire a privately owned ophthalmic biotechnology company, the drug maker said Monday.

02/10/2012 - 11:18am

An expert panel at the Food and Drug Administration has given a thumbs-down to a drug made by Astex Pharmaceuticals and Eisai for which the two had sought approval as a treatment for leukemia.

02/09/2012 - 3:12pm

The Food and Drug Administration reached a major milestone on the path to a regulatory regime for follow-on biologics on Thursday with the release of draft guidance on biosimilar product development.

02/08/2012 - 5:00pm

While the financial burden that families face due to prescription drugs has declined, costs nevertheless remain a challenge for many of them, according to a new study by nonprofit research organization Rand Corp.

02/08/2012 - 12:18pm

Specialty pharmacy provider The Apothecary Shops has inked a deal with Pfizer to distribute a new drug for treating kidney cancer.

02/08/2012 - 10:55am

Specialty pharmacy company Amber Pharmacy has implemented a prior authorization system provided by Armada Health Care, Amber said.